SAB Biotherapeutics
SAB Biotherapeutics is advancing in the development of an antibody therapeutic to treat Covid-19
Rankings by
National Ranking473rd
in United States Regional Ranking537th
in North America and Caribbean Global Ranking1289th
worldwide